# Testing Doxazosin to Treat Stress Mechanisms in Alcoholism

> **NCT02989493** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 61 (actual)

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Doxazosin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02989493
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02989493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02989493, "Testing Doxazosin to Treat Stress Mechanisms in Alcoholism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02989493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*